DAVID KIRSKE Insider Profile
4 Followers
DAVID KIRSKE, EVP & CFO at CTI BioPharma, holds 176.29K shares in X4 Pharmaceuticals (Ticker: XFOR), holds 0.00 shares in CTI BioPharma (Ticker: CTIC). Most recently, DAVID KIRSKE Sold ― shares of X4 Pharmaceuticals on May 13, 2026 for an estimated value of $72.76K.
DAVID KIRSKE CTI BioPharma (CTIC)EVP & CFO
CTI BioPharma (CTIC)
EVP & CFO
Not Ranked
DAVID KIRSKE has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO
Roles that DAVID KIRSKE holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by DAVID KIRSKE
DAVID KIRSKE's Trading History
CTI BioPharma
Jun 26, 2023
―
Uninformative Sell
159.68K
$0.00
X4 Pharmaceuticals
May 13, 2026
CFO
Informative Sell
72.76K
$712.22K
List of latest transactions for each holding click on a transaction to see DAVID KIRSKE's performance on stock
You May Also Like
DAVID KIRSKE insider profile FAQ
What is the percentage of profitable transactions made by DAVID KIRSKE?
The percentage of profitable transactions made by DAVID KIRSKE is ―.
What is the average return per transaction made by DAVID KIRSKE?
The average return per transaction made by DAVID KIRSKE is ―.
What stocks does DAVID KIRSKE hold?
DAVID KIRSKE holds: CTIC, XFOR stocks.
What was DAVID KIRSKE’s latest transaction?
DAVID KIRSKE latest transaction was an Informative Sell of $72.76K.
What was DAVID KIRSKE's most profitable transaction?
DAVID KIRSKE’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is DAVID KIRSKE's role in CTI BioPharma?
DAVID KIRSKE's role in CTI BioPharma is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.